These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2490504)

  • 21. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonclassical MHC-I and Japanese encephalitis virus infection: induction of H-2Q4, H-2T23 and H-2T10.
    Abraham S; Yaddanapudi K; Thomas S; Damodaran A; Ramireddy B; Manjunath R
    Virus Res; 2008 May; 133(2):239-49. PubMed ID: 18314211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some behavioral consequences of H-2:Qa:Tla polymorphism.
    Boyse EA
    Cell Immunol; 1983 Nov; 82(1):33-5. PubMed ID: 6357488
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular genetics of class I genes in the mammalian major histocompatibility complex.
    Mellor AL
    Oxf Surv Eukaryot Genes; 1986; 3():95-140. PubMed ID: 3334367
    [No Abstract]   [Full Text] [Related]  

  • 26. The biochemical genetics of the Qa-Tla region.
    Michaelson J; Boyse EA; Chorney M; Flaherty L; Fleissner E; Hämmerling U; Reinisch C; Rosenson R; Shen FW
    Transplant Proc; 1983 Dec; 15(4):2033-8. PubMed ID: 6673205
    [No Abstract]   [Full Text] [Related]  

  • 27. The expression of an "alloantigen"-like molecule is a general phenomenon in AKR leukaemias.
    Labeta M; Fernandez N; Festenstein H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):578. PubMed ID: 2705236
    [No Abstract]   [Full Text] [Related]  

  • 28. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P; Gisselbrecht S; Boyer B; Levy JP
    Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description of a new Qa antigenic specificity, "Qa-m9," whose expression is under complex genetic control.
    Sutton VR; Hogarth PM; McKenzie IF
    J Immunol; 1983 Sep; 131(3):1363-7. PubMed ID: 6193187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock proteins can regulate expression of the Tla region-encoded class Ib molecule Qa-1.
    Imani F; Soloski MJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10475-9. PubMed ID: 1961712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagen-induced antigenic variants of tumor cells.
    Boon T; Van Pel A; De Plaen E; Vessière F
    Symp Fundam Cancer Res; 1986; 38():139-48. PubMed ID: 3489258
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TL region gene 37 encodes a Qa-1 antigen.
    Wolf PR; Cook RG
    J Exp Med; 1990 Dec; 172(6):1795-804. PubMed ID: 2258708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface markers, antigens, and receptors on murine T and B cells: part 2.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1983; 4(1):19-94. PubMed ID: 6131792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of MHC class I-peptide tetrameric complexes for analysis of T-cell-mediated immune responses.
    Samuel RV; Hanke T
    Methods Mol Med; 2003; 87():279-88. PubMed ID: 12958462
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic constitution of an H-2:Tla variant leukemia.
    Shen FW; Chaganti RS; Doucette LA; Litman GW; Steinmetz M; Hood L; Boyse EA
    Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6447-50. PubMed ID: 6593710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A glycophospholipid anchor is required for Qa-2-mediated T cell activation.
    Robinson PJ; Millrain M; Antoniou J; Simpson E; Mellor AL
    Nature; 1989 Nov; 342(6245):85-7. PubMed ID: 2530453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific mutagenesis of the class I regulatory element the Q10 gene allows expression in non-liver tissues.
    Handy DE; Burke PA; Ozato K; Coligan JE
    J Immunol; 1989 Feb; 142(3):1015-21. PubMed ID: 2913151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex.
    Ostrand-Rosenberg S; Nickerson DA; Clements VK; Garcia EP; Lamouse-Smith E; Hood L; Stroynowski I
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5084-8. PubMed ID: 2740345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.